Dongju Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dongju Lim has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jae Kyoung Kim
Institute for Basic Science
7 shared publications Juhyeon Kim
Department of Mathematical Sciences, KAIST, Daejeon, Republic of Korea
2 shared publicationsBoseung Choi
Affiliations Biomedical Mathematics Group, Pioneer Research Center for Mathematical and Computational Sciences, Institute for Basic Science, Daejeon, Republic of Korea, Division of Big Data Science, Korea University, Sejong, Republic of Korea, College of Public Health, The Ohio State University, Ohio, United States of America
1 shared publicationByung-Kwan Cho
1 shared publication- Eun Yeon Joo
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 shared publication - Hea Ree Park
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- 2 April 2026
- Published by SAGE Publications in Journal of Biological Rhythms
- Vol. 41 (4) , 435-449
Initial Condition Decision to Ensure Reliable Circadian Phase Estimation With Shorter-Term Wearable Data
Various studies in the medical field highlight the importance of circadian medicine, which optimizes treatment timing based on patients’ circadian phases. While the circadian phase has been measured using dim light melatonin onset (DLMO), the gold standard marker, its high cost and time-intensive nature have led to the development of alternative estimation methods. Among these, the most promising method is using ordinary differential equation (ODE) models, which simulate the circadian rhythm by using a light exposure profile estimated from sleep data. These ODE models require an initial condition (IC) representing the initial state of the circadian rhythm, which is unknown in real-world settings. However, it is unclear how the uncertainty of IC affects the accuracy of circadian phase estimation. In this study, by using sleep data collected from 28 shift workers using ActiWatch (mean duration = 56 days, range = 34-75 days), we found that ≥18 days of sleep data are required for the circadian phase to become independent of the subjective IC choice. The result showed that without an accurate IC, circadian phase estimation is dependent on subjective IC choice, meaning that circadian phase estimates in the first 17 days are not reliable. Indeed, these days were reduced to 11-14 days on average when previous studies’ IC estimation methods were used. To further shorten this length, we developed new IC estimation methods—period-based and work history–based sleep methods—that incorporate daily variations in sleep history. Notably, the new methods reduced the number of days required for reliable circadian phase estimation to about 5 days. Hence, our approach allows a larger portion of circadian phase estimates from given sleep data to be used as reliable information. The superiority of our methods paves the way for improved circadian phase estimation, ultimately enhancing the practicality of chronotherapy applications.
- 2 April 2026
- Published by SAGE Publications in Journal of Biological Rhythms
- Vol. 41 (4) , 435-449
Initial Condition Decision to Ensure Reliable Circadian Phase Estimation With Shorter-Term Wearable Data
Various studies in the medical field highlight the importance of circadian medicine, which optimizes treatment timing based on patients’ circadian phases. While the circadian phase has been measured using dim light melatonin onset (DLMO), the gold standard marker, its high cost and time-intensive nature have led to the development of alternative estimation methods. Among these, the most promising method is using ordinary differential equation (ODE) models, which simulate the circadian rhythm by using a light exposure profile estimated from sleep data. These ODE models require an initial condition (IC) representing the initial state of the circadian rhythm, which is unknown in real-world settings. However, it is unclear how the uncertainty of IC affects the accuracy of circadian phase estimation. In this study, by using sleep data collected from 28 shift workers using ActiWatch (mean duration = 56 days, range = 34-75 days), we found that ≥18 days of sleep data are required for the circadian phase to become independent of the subjective IC choice. The result showed that without an accurate IC, circadian phase estimation is dependent on subjective IC choice, meaning that circadian phase estimates in the first 17 days are not reliable. Indeed, these days were reduced to 11-14 days on average when previous studies’ IC estimation methods were used. To further shorten this length, we developed new IC estimation methods—period-based and work history–based sleep methods—that incorporate daily variations in sleep history. Notably, the new methods reduced the number of days required for reliable circadian phase estimation to about 5 days. Hence, our approach allows a larger portion of circadian phase estimates from given sleep data to be used as reliable information. The superiority of our methods paves the way for improved circadian phase estimation, ultimately enhancing the practicality of chronotherapy applications.
- Open Access
Exact formula of the total quasi-steady state approximation in competitive target-mediated drug disposition
Competitive target-mediated drug disposition (competitive TMDD) arises when two drugs compete for the same target receptor. These dynamics can be characterized by the full competitive TMDD model; yet, its complexity motivated the use of a reduced model, which is invalid under high receptor concentrations. While this problem can be resolved by using the total quasi-steady state approximation (tQSSA), which remains valid for all receptor conditions, the exact formula of the tQSSA-based reduced model—competitive qTMDD—has remained unknown for 15 years, as it requires solving a cubic equation and the nontrivial task of identifying a biologically meaningful solution. Consequently, researchers have relied on numerical approximation methods, which impose substantial computational costs to maintain accuracy and thereby hinder their practical use in complex real-world applications. To address this problem, we derive—for the first time—a real-valued exact formula for competitive qTMDD by leveraging analytic properties of cubic equations and geometric characteristics of their roots in the complex plane. This exact formula improved computational speed by more than 11-fold compared to previous numerical approximation methods, thereby enabling Bayesian inference using competitive qTMDD, which had been impractical due to excessive computational time. When applied to real-world data from clinical trials, competitive qTMDD estimated pharmacological parameter estimates comparable to those from the full competitive TMDD model while requiring only 30-43% of the computation time. Importantly, this estimation using competitive qTMDD remained consistently accurate regardless of data sparsity, whereas the previous reduced model produced biased estimates under sparse sampling conditions. By ensuring precise biological interpretation of drug systems even in complex real-world scenarios, the exact formula of competitive qTMDD has the potential to significantly streamline the drug development and clinical testing process. Our exact formula also consists entirely of real-valued terms, allowing seamless integration into existing pharmacometrics software. Author Summary: Competitive target-mediated drug disposition (competitive TMDD) occurs when two drugs compete for the same target receptor. Analyzing this interaction has faced a dilemma for 15 years: choosing between a ‘full model’ that is accurate but computationally intensive, and a ‘reduced model’ that is fast but often loses accuracy under real-world clinical conditions. Researchers tried to solve this dilemma by deriving an accurate reduced model; however, it was mathematically challenging. As a result, they had to rely on numerical approximations—which require substantial computational power to maintain the accuracy needed for clinical use, making them impractical in real-world scenarios. In this study, we derive a first-ever exact formula for the new reduced model that is accurate across all biological conditions. This formula computes more than 11 times faster than previous numerical methods, making advanced statistical analyses—such as Bayesian inference—feasible for the first time in this context. When applied to real-world clinical data for Anakinra and rhIL-7-hyFc, our method yielded parameter estimates as accurate as the full model but required significantly less computation time. This breakthrough provides a more accurate biological interpretation and better guidance for determining the right drug dose, potentially accelerating drug development and reducing associated costs.
Open AccessExact formula of the total quasi-steady state approximation in competitive target-mediated drug disposition
Competitive target-mediated drug disposition (competitive TMDD) arises when two drugs compete for the same target receptor. These dynamics can be characterized by the full competitive TMDD model; yet, its complexity motivated the use of a reduced model, which is invalid under high receptor concentrations. While this problem can be resolved by using the total quasi-steady state approximation (tQSSA), which remains valid for all receptor conditions, the exact formula of the tQSSA-based reduced model—competitive qTMDD—has remained unknown for 15 years, as it requires solving a cubic equation and the nontrivial task of identifying a biologically meaningful solution. Consequently, researchers have relied on numerical approximation methods, which impose substantial computational costs to maintain accuracy and thereby hinder their practical use in complex real-world applications. To address this problem, we derive—for the first time—a real-valued exact formula for competitive qTMDD by leveraging analytic properties of cubic equations and geometric characteristics of their roots in the complex plane. This exact formula improved computational speed by more than 11-fold compared to previous numerical approximation methods, thereby enabling Bayesian inference using competitive qTMDD, which had been impractical due to excessive computational time. When applied to real-world data from clinical trials, competitive qTMDD estimated pharmacological parameter estimates comparable to those from the full competitive TMDD model while requiring only 30-43% of the computation time. Importantly, this estimation using competitive qTMDD remained consistently accurate regardless of data sparsity, whereas the previous reduced model produced biased estimates under sparse sampling conditions. By ensuring precise biological interpretation of drug systems even in complex real-world scenarios, the exact formula of competitive qTMDD has the potential to significantly streamline the drug development and clinical testing process. Our exact formula also consists entirely of real-valued terms, allowing seamless integration into existing pharmacometrics software. Author Summary: Competitive target-mediated drug disposition (competitive TMDD) occurs when two drugs compete for the same target receptor. Analyzing this interaction has faced a dilemma for 15 years: choosing between a ‘full model’ that is accurate but computationally intensive, and a ‘reduced model’ that is fast but often loses accuracy under real-world clinical conditions. Researchers tried to solve this dilemma by deriving an accurate reduced model; however, it was mathematically challenging. As a result, they had to rely on numerical approximations—which require substantial computational power to maintain the accuracy needed for clinical use, making them impractical in real-world scenarios. In this study, we derive a first-ever exact formula for the new reduced model that is accurate across all biological conditions. This formula computes more than 11 times faster than previous numerical methods, making advanced statistical analyses—such as Bayesian inference—feasible for the first time in this context. When applied to real-world clinical data for Anakinra and rhIL-7-hyFc, our method yielded parameter estimates as accurate as the full model but required significantly less computation time. This breakthrough provides a more accurate biological interpretation and better guidance for determining the right drug dose, potentially accelerating drug development and reducing associated costs.
- Open Access
Initial Condition Decision to Ensure Reliable Circadian Phase Estimation with Shorter-Term Wearable Data
Various studies in the medical field highlight the importance of circadian medicine, which optimizes treatment timing based on patients’ circadian phases. While the circadian phase has been measured using dim light melatonin onset (DLMO), the gold standard marker, its high cost and time-intensive nature have led to the development of alternative estimation methods. Among these, the most promising method is using ordinary differential equation (ODE) models, which simulate the circadian rhythm by using a light exposure profile estimated from sleep data. These ODE models require an initial condition (IC) representing the initial state of the circadian rhythm, which is unknown in real-world settings. However, it is unclear how the uncertainty of IC affects the accuracy of circadian phase estimation. In this study, by using sleep data collected from 28 shift workers using ActiWatch (mean duration = 56 days, range = 34–75 days), we found that ≥18 days of sleep data are required for the circadian phase to become independent of the subjective IC choice. The result showed that without an accurate IC, circadian phase estimation is dependent on subjective IC choice, meaning that circadian phase estimates in the first 17 days are not reliable. Indeed, these days were reduced to 13 – 15 days on average when previous studies’ IC estimation methods were used. To further shorten this length, we developed new IC estimation methods—period- and work history-based sleep methods—that incorporate daily variations in sleep history. Notably, the new methods reduced the number of days required for reliable circadian phase estimation to about seven days. Hence, our approach allows a larger portion of circadian phase estimates from given sleep data to be used as reliable information. The superiority of our methods paves the way for improved circadian phase estimation, ultimately enhancing the practicality of chronotherapy applications.
Open AccessInitial Condition Decision to Ensure Reliable Circadian Phase Estimation with Shorter-Term Wearable Data
Various studies in the medical field highlight the importance of circadian medicine, which optimizes treatment timing based on patients’ circadian phases. While the circadian phase has been measured using dim light melatonin onset (DLMO), the gold standard marker, its high cost and time-intensive nature have led to the development of alternative estimation methods. Among these, the most promising method is using ordinary differential equation (ODE) models, which simulate the circadian rhythm by using a light exposure profile estimated from sleep data. These ODE models require an initial condition (IC) representing the initial state of the circadian rhythm, which is unknown in real-world settings. However, it is unclear how the uncertainty of IC affects the accuracy of circadian phase estimation. In this study, by using sleep data collected from 28 shift workers using ActiWatch (mean duration = 56 days, range = 34–75 days), we found that ≥18 days of sleep data are required for the circadian phase to become independent of the subjective IC choice. The result showed that without an accurate IC, circadian phase estimation is dependent on subjective IC choice, meaning that circadian phase estimates in the first 17 days are not reliable. Indeed, these days were reduced to 13 – 15 days on average when previous studies’ IC estimation methods were used. To further shorten this length, we developed new IC estimation methods—period- and work history-based sleep methods—that incorporate daily variations in sleep history. Notably, the new methods reduced the number of days required for reliable circadian phase estimation to about seven days. Hence, our approach allows a larger portion of circadian phase estimates from given sleep data to be used as reliable information. The superiority of our methods paves the way for improved circadian phase estimation, ultimately enhancing the practicality of chronotherapy applications.
- Open Access
Toward Single-Cell Control: Noise-Robust Perfect Adaptation in Biomolecular Systems
Robust perfect adaptation (RPA), whereby a consistent output level is maintained even after a disturbance, is a highly desired feature in biological systems. This property can be achieved at the population average level by combining the well-known antithetic integral feedback (AIF) loop into the target network. However, the AIF controller amplifies the noise of the output level, disrupting the single-cell level regulation of the system output and compromising the conceptual goal of stable output level control. To address this, we introduce a new regulation motif, the noise controller, which is inspired by the AIF loop but differs by sensing the output levels through the dimerization of output species. Combining this noise controller with the AIF controller successfully maintained system output noise as well as mean at their original level, even after the perturbation, thereby achieving noise RPA. Furthermore, our noise controller could reduce the output noise to a desired target value, achieving a Fano factor as small as 1, the commonly recognized lower bound of intrinsic noise in biological systems. Notably, our controller remains effective as long as the combined system is ergodic, making it applicable to a broad range of networks. We demonstrate its utility by combining the noise controller with the DNA repair system of Escherichia coli , which reduced the proportion of cells failing to initiate the DNA damage response. These findings enhance the precision of existing biological controllers, marking a key step toward achieving single-cell level regulation.
Open AccessToward Single-Cell Control: Noise-Robust Perfect Adaptation in Biomolecular Systems
Robust perfect adaptation (RPA), whereby a consistent output level is maintained even after a disturbance, is a highly desired feature in biological systems. This property can be achieved at the population average level by combining the well-known antithetic integral feedback (AIF) loop into the target network. However, the AIF controller amplifies the noise of the output level, disrupting the single-cell level regulation of the system output and compromising the conceptual goal of stable output level control. To address this, we introduce a new regulation motif, the noise controller, which is inspired by the AIF loop but differs by sensing the output levels through the dimerization of output species. Combining this noise controller with the AIF controller successfully maintained system output noise as well as mean at their original level, even after the perturbation, thereby achieving noise RPA. Furthermore, our noise controller could reduce the output noise to a desired target value, achieving a Fano factor as small as 1, the commonly recognized lower bound of intrinsic noise in biological systems. Notably, our controller remains effective as long as the combined system is ergodic, making it applicable to a broad range of networks. We demonstrate its utility by combining the noise controller with the DNA repair system of Escherichia coli , which reduced the proportion of cells failing to initiate the DNA damage response. These findings enhance the precision of existing biological controllers, marking a key step toward achieving single-cell level regulation.
- Open Access
- 5 September 2025
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 21 (9) , e1013438
A history-dependent approach for accurate initial condition estimation in epidemic models
Mathematical modeling is a powerful tool for understanding and predicting complex dynamical systems, ranging from gene regulatory networks to population-level dynamics. However, model predictions are highly sensitive to initial conditions, which are often unknown. In infectious disease models, for instance, the initial number of exposed individuals (E) at the time the model simulation starts is frequently unknown. This initial condition has often been estimated using an unrealistic, history-independent assumption for simplicity: the chance that an exposed individual becomes infectious is the same regardless of the timing of their exposure (i.e., exposure history). Here, we show that this history-independent method can yield serious bias in the estimation of the initial condition. To address this, we developed a history-dependent initial condition estimation method derived from a master equation expressing the time-varying likelihood of becoming infectious during a latent period. Our method consistently outperformed the history-independent method across various scenarios, including those with measurement errors and abrupt shifts in epidemics, for example, due to vaccination. In particular, our method reduced estimation error by 55% compared to the previous method in real-world COVID-19 data from Seoul, Republic of Korea, which includes likely infection dates, allowing us to obtain the true initial condition. This advancement of initial condition estimation enhances the precision of epidemic modeling, ultimately supporting more effective public health policies. We also provide a user-friendly package, Hist-D, to facilitate the use of this history-dependent initial condition estimation method.
- 5 September 2025
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 21 (9) , e1013438
Open AccessA history-dependent approach for accurate initial condition estimation in epidemic models
Mathematical modeling is a powerful tool for understanding and predicting complex dynamical systems, ranging from gene regulatory networks to population-level dynamics. However, model predictions are highly sensitive to initial conditions, which are often unknown. In infectious disease models, for instance, the initial number of exposed individuals (E) at the time the model simulation starts is frequently unknown. This initial condition has often been estimated using an unrealistic, history-independent assumption for simplicity: the chance that an exposed individual becomes infectious is the same regardless of the timing of their exposure (i.e., exposure history). Here, we show that this history-independent method can yield serious bias in the estimation of the initial condition. To address this, we developed a history-dependent initial condition estimation method derived from a master equation expressing the time-varying likelihood of becoming infectious during a latent period. Our method consistently outperformed the history-independent method across various scenarios, including those with measurement errors and abrupt shifts in epidemics, for example, due to vaccination. In particular, our method reduced estimation error by 55% compared to the previous method in real-world COVID-19 data from Seoul, Republic of Korea, which includes likely infection dates, allowing us to obtain the true initial condition. This advancement of initial condition estimation enhances the precision of epidemic modeling, ultimately supporting more effective public health policies. We also provide a user-friendly package, Hist-D, to facilitate the use of this history-dependent initial condition estimation method.
- Open Access
- 4 August 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (12)
More than just slowing: bimodal vigilance dynamics in sleep deprivation
- 4 August 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 48 (12)
Open AccessMore than just slowing: bimodal vigilance dynamics in sleep deprivation
- 27 February 2025
- Published by SAGE Publications in Journal of Biological Rhythms
- Vol. 40 (3) , 249-261
Enhanced Circadian Phase Tracking: A 5-h DLMO Sampling Protocol Using Wearable Data
Circadian medicine aims to leverage the body’s internal clock to develop safer and more effective therapeutics. Traditionally, biological time has been estimated using dim light melatonin onset (DLMO), a method that requires collecting saliva samples over a long period under controlled conditions, to ensure the observation of DLMO, making it time-consuming and labor-intensive. While some studies have mitigated this by reducing the length of the sampling window, they significantly failed to identify the DLMO for shift workers. In this study, we present a framework that reduces the DLMO experiment time for shift workers to just 5 h. This approach combines sleep-wake pattern data from wearable devices with a mathematical model to predict DLMO prospectively. Based on this prediction, we define a targeted 5-h sampling window, from 3 h before to 2 h after the estimated DLMO. Testing this framework with 19 shift workers, we successfully identified the DLMO for all participants, whereas traditional methods failed for more than 40% of participants. This approach significantly reduces the experiment time required for measuring the DLMO of shift workers from 24 h to 5 h, simplifying the circadian phase measurements for shift workers.
- 27 February 2025
- Published by SAGE Publications in Journal of Biological Rhythms
- Vol. 40 (3) , 249-261
Enhanced Circadian Phase Tracking: A 5-h DLMO Sampling Protocol Using Wearable Data
Circadian medicine aims to leverage the body’s internal clock to develop safer and more effective therapeutics. Traditionally, biological time has been estimated using dim light melatonin onset (DLMO), a method that requires collecting saliva samples over a long period under controlled conditions, to ensure the observation of DLMO, making it time-consuming and labor-intensive. While some studies have mitigated this by reducing the length of the sampling window, they significantly failed to identify the DLMO for shift workers. In this study, we present a framework that reduces the DLMO experiment time for shift workers to just 5 h. This approach combines sleep-wake pattern data from wearable devices with a mathematical model to predict DLMO prospectively. Based on this prediction, we define a targeted 5-h sampling window, from 3 h before to 2 h after the estimated DLMO. Testing this framework with 19 shift workers, we successfully identified the DLMO for all participants, whereas traditional methods failed for more than 40% of participants. This approach significantly reduces the experiment time required for measuring the DLMO of shift workers from 24 h to 5 h, simplifying the circadian phase measurements for shift workers.